Evidence map›Paper›PMID 25285557›Full record

ArticleAnnals of internal medicine2014

Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1.

J L Lennox, R J Landovitz, H J Ribaudo, I Ofotokun, L H Na, C Godfrey, D R Kuritzkes, M Sagar, T T Brown, S E Cohn and 14 more

Abstract readPatient Education Handout
PubMed Publisher
In one paragraph

Article in Annals of internal medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 67% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

J L Lennox
R J Landovitz
H J Ribaudo
I Ofotokun
L H Na
C Godfrey
D R Kuritzkes
M Sagar
T T Brown
S E Cohn
G A McComsey
F Aweeka
C J Fichtenbaum
R M Presti
S L Koletar
D W Haas
K B Patterson
C A Benson
B P Baugh
R Y Leavitt
J F Rooney
D Seekins
J S Currier
ACTG A5257 Team

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Clinical and Translational Science Collaborative of ClevelandUL1TR002548 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI MCCOMSEY, GRACE A · 2018 to 2022
$35.5M
Clinical and Translational Science Collaborative of Northern Ohio, Catalyzing Linkages to Equity in Health (CLE Health)UM1TR004528 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI GRACE A MCCOMSEY · 2023 to 2026
$32.1M
NCATS NIH HHS UL1 TR000439NCATS NIH HHS UL1 TR002548NCATS NIH HHS UM1 TR004528NIAID NIH HHS P30 AI027763
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HIV-1Anti-Retroviral AgentsDrug TherapyHIV InfectionsHumansReverse Transcriptase InhibitorsAnti-Retroviral AgentsReverse Transcriptase Inhibitors

Identifiers

PMID25285557
OpenAlexW2405054405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.